TGF-β gene polymorphism does not influence the rise in creatinine following cardiac transplantation

Transplant Immunology

Volumn 7, Issue 4, 1999, Pages 247-249

  Densem, Cameron G ^a   Hutchinson, Ian V ^b   Yonan, Nizaar ^a   Brooks, Nicholas H ^a  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOSPORIN A; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CREATININE BLOOD LEVEL; DNA POLYMORPHISM; GENOTYPE; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NEPHROTOXICITY; PRIORITY JOURNAL;

EID: 0033396836     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(99)80009-4     Document Type: Article

References (6)

1. Myers BD, Ross J, Newton L, Lyetscher J, Perloth M. Cyclosporine-associated chronic nephropathy. N Engl J Med. 311:1984;699-705.
2. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med. 331:1994;1286-1292.
3. Khanna AK, Cairns VR, Becker CG, Hosenpud JD. TGF-β: a link between immunosuppression, nephrotoxicity and CsA. Transplant Proc. 30:1998;944-945.
4. Award MR, El-Gamel A, Hastleton P, et al. Genotypic variation in the transforming growth factor beta-1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease and graft fibrosis after lung transplantation. Transplantation. 66:1998;1014-1020.
5. Cambien F, Ricard S, Troesch A, et al. Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Temoin de i'Infarctus du Myocarde (ECTIM) Study. Hypertension. 28:1996;881-887.
6. Densem CG, Hutchinson IV, Cooper A, Roberts T, Yonan N, Brooks NH. Low producers of TGF beta are protected from cardiac transplant vasculopathy [abstract]. J Heart Lung Transplant. 18:1999;52.